MANU Manchester United Plc

Explanatory Note

This Amendment No. 6 to Schedule 13D (“Amendment No. 6”) amends and supplements the Schedule 13D filed with the United States Securities and Exchange Commission on August 23, 2013 (as amended to date, the “Schedule 13D”), relating to the Class A ordinary shares, par value $0.0005 per share (the “Class A ordinary shares”) of Manchester United plc, a Cayman Islands company (the “Issuer”). This Amendment No. 6 is filed by the Kevin E. Glazer Irrevocable Exempt Family Trust (the “Trust”), KEGT Holdings LLC (the “LLC”) and Kevin E. Glazer (the “Trustee” and, together with the Trust and the LLC, the “Reporting Persons”). Capitalized terms used herein without definition shall have the meaning set forth in the Schedule 13D.

Item 4 of the Schedule 13D is hereby amended and supplemented by inserting the following information.

Strategic Process

On November 22, 2022, the Issuer announced that the Issuer’s board of directors (the “Board”) was commencing a process to explore strategic alternatives, including, new investments into the Issuer, or a sale, merger, or other transaction involving the Issuer (the “Strategic Process”).

As part of the Strategic Process, the Reporting Persons intend to engage in discussions with third-parties, management, the Board, other representatives of the Issuer, and/or with other holders of securities of the Issuer. In connection with these discussions, the Reporting Persons, including Mr. Glazer in his position as a member of the Board, may suggest, take a position regarding, or participate in, a variety of matters relating to the Strategic Process, which may include, among other things, suggesting changes to the Issuer’s operations, management, corporate governance, capital structure, and control, as well as other alternatives that relate to or would result in: an extraordinary corporate transactions, such as a merger, tender-offer, take-private, or other transaction that could result in the delisting or deregistration of the Class A ordinary shares; changes to the capitalization or dividend policy of the Issuer; or other material changes to the Issuer’s business or corporate structure, including changes to the Issuer’s charter or bylaws or changes in management or the composition of the Board.

To facilitate their consideration of such matters, the Reporting Persons, in their individual capacity, intend to retain consultants and advisors and may enter into discussions with potential sources of capital and other third parties. The Reporting Persons may exchange information with any such persons pursuant to appropriate confidentiality or similar agreements. The Reporting Persons will likely take some or all of the foregoing steps at preliminary stages in their consideration of various possible courses of action before forming any intention to pursue any particular plan or direction.

As a result of these considerations or as a result of the Strategic Process, the Reporting Persons may, from time to time and at any time, (a) acquire additional securities of the Issuer in open market transactions, privately negotiated transactions, through a tender offer or otherwise, or (b) dispose of any or all of their securities of the Issuer in open market transactions, privately negotiated transactions, in connection with an extraordinary corporate transaction, or otherwise.

Except as described in this Schedule 13D, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, although, subject to the agreements described herein, the Reporting Persons, at any time and from time to time, may review, reconsider and change their position and/or change their purpose and/or develop such plans and may seek to influence management or the Board with respect to the business and affairs of the Issuer and may from time to time consider pursuing or proposing such matters with advisors, the Issuer or other persons.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 22, 2022